Microalgal carotenoids and phytosterols regulate biochemical mechanisms involved in human health and disease prevention.
Apoptosis
/ drug effects
Carbohydrate Metabolism
/ drug effects
Cardiovascular Diseases
/ prevention & control
Cholesterol
/ analogs & derivatives
Dietary Supplements
Humans
Lipid Metabolism
/ drug effects
Metabolic Diseases
/ prevention & control
Microalgae
/ metabolism
Neoplasms
/ prevention & control
Phytosterols
/ pharmacology
Signal Transduction
Sitosterols
/ pharmacology
Xanthophylls
/ pharmacology
Cell signaling pathway regulation
Chronic disease prevention
Microalgae
Phytosterols
Xanthophylls
Journal
Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
26
04
2019
accepted:
18
09
2019
pubmed:
24
9
2019
medline:
7
1
2020
entrez:
24
9
2019
Statut:
ppublish
Résumé
Microalgae are photosynthetic microorganisms that produce numerous bioactive molecules that can be used as food supplement to prevent chronic disease installation. Indeed, they produce phycobiliproteins, polysaccharides, lipids, carotenoids and sterolic compounds. The use of microalgae in human nutrition provide a mixture of these molecules with synergistic effect. The aim of this review is to present the specific roles played by the xanthophylls, and specifically astaxanthin and fucoxanthin, two high added value carotenoids, and by microalgal phytosterols such as β-sitosterol, campesterol and stigmasterol on several cell mechanisms involved in the prevention of cardiometabolic diseases and cancers. This review explains how these microalgal molecules modulate cell signaling pathways involved in carbohydrate and lipid metabolisms, inflammation, apoptosis, invasion and metastasis. Xanthophylls and phytosterols are involved in the reduction of inflammatory markers in relation with the regulation of the c-Jun N-terminal kinases and nuclear factor-kappa B signaling pathways, and suppression of production of pro-inflammatory mediators. Xanthophylls act on glucose and lipid metabolisms via both the upregulation of peroxisome proliferator-activated receptors (PPARs) and glucose transporters and its effects on the expression of enzymes involved in fatty acid synthesis and cholesterol metabolism. Their anti-cancer effects are related to the induction of intrinsic apoptosis due to down-regulation of key regulatory kinases. The anti-angiogenesis, anti-proliferative and anti-invasive effects are correlated with decreased production of endothelial growth factors and of matrix metalloproteinases. Phytosterols have a major role on cholesterol absorption via modification of the activities of Niemann-Pick C1 like 1 and ATP-binding cassette transporters and on cholesterol esterification. Their action are also related with the modulation of PPARs and sterol regulatory element-binding protein-1 activities.
Identifiants
pubmed: 31545993
pii: S0300-9084(19)30270-6
doi: 10.1016/j.biochi.2019.09.012
pii:
doi:
Substances chimiques
Phytosterols
0
Sitosterols
0
Xanthophylls
0
fucoxanthin
06O0TC0VSM
campesterol
5L5O665639
gamma-sitosterol
5LI01C78DD
astaxanthine
8XPW32PR7I
Cholesterol
97C5T2UQ7J
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
106-118Informations de copyright
Copyright © 2019 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.